China BlueChemical Ltd. filed its Monthly Return for the period ended 31 March 2026, confirming an essentially unchanged equity profile and continued compliance with Hong Kong’s public-float rules.

Authorised / registered capital • The company’s authorised share capital remained at RMB 4.61 billion, split between 1.80 billion H shares and 2.81 billion domestic shares, each with a par value of RMB 1. • The only technical movement was an increase of one domestic share, leaving totals effectively flat versus February.

Issued shares and treasury shares • Issued H shares: 1.80 billion, unchanged month-on-month. • Issued domestic shares: 2.81 billion, unchanged. • No treasury shares were held or cancelled during the month, maintaining the total issued share count at 4.61 billion.

Public-float confirmation • China BlueChemical confirmed that its H-share public float satisfies the Main Board minimum threshold of 25 percent of the class’s issued shares.

Capital instruments • The company reported no outstanding share options, warrants, convertibles or other equity-linked instruments.

Administrative details • The return was signed by Company Secretary Kuang Xiaobing and submitted to Hong Kong Exchanges and Clearing on 2 April 2026.

The filing signals a steady capital base with no equity dilution events in March, while reaffirming regulatory compliance on public float and share-registration requirements.